• jump to: Main navigation
  • jump to: Main content
  • jump to: Footer

Callaghan Innovation
logo - print

Search form
  • home
    • Access to
      experts
      • Māori Economy
      • Founder Incubators
      • Accelerators
      • Technology Incubators
      • Networks
      • Collaborative projects
      • Enterprise Europe Network (EEN)
      • Hemp and medicinal cannabis capability roadmaps
      • Health Tech Activator website

      All access to experts services

      Time to get in touch?

      Contact us now

    • Technology
      and product development
      • Our R&D services website
      • Gracefield Innovation Quarter
      • Te Whare a Māui - The Māori Innovation Hub
      • Manufacturing robots
      • Digital Energy Hub
      • Industry 4.0 Hub
      • The AddLab

      All technology and product development services

      Time to get in touch?

      Contact us now

    • Innovation
      skills
      • Build for Speed website
      • Capital Education
      • Lean
      • Digital Lean
      • Innovation IP

      All innovation skills services

      Time to get in touch?

      Contact us now

    • R&D
      funding
      • Student Grants
      • Getting Started Grants
      • Project Grants
      • Growth Grants
      • R&D Tax Incentive
      • R&D Loan Scheme
      • Guidelines and FAQs
      • Grant Recipients

      All r&d funding services

      Time to get in touch?

      Contact us now

    • Scale-Up NZ

      All scale-up nz services

      Time to get in touch?

      Contact us now

  • About us
  • News and events
  • Customer stories
  • Careers
  • Contact us
  • Search

Callaghan Innovation Research Papers

Back to Research Papers

TitleAnalysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains
Publication TypeJournal Article
Year of Publication2017
AuthorsSingh, A., MacKenzie A., Girnun G., and Poeta M.D.
JournalJournal of Lipid Research
Volume58
Issue10
Pagination2017 - 2036
Date Published2017
ISSN00222275 (ISSN)
Keywordsalpha hydroxy phytoceramide, article, controlled study, Cryptococcus gattii, Cryptococcus grubii, dihydroceramide, dihydrosphingosine 1 phosphate, enzyme metabolism, ergosterol, Filobasidiella, fungal cell, fungal strain, fungal virulence, glucosylceramide, inositolphosphorylceramide, lipid, lipid analysis, lipid metabolism, liquid chromatography-mass spectrometry, lysophosphatidylethanolamine, nonhuman, phosphatidic acid, phosphatidyl n monomethylethanolamine, phosphatidyl n,n dimethylethanolamine, Phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine, phospholipid, phytoceramide, phytosphingosine, phytosphingosine 1 phosphate, priority journal, species differentiation, Spectroscopy, sphinganine, sphingolipid, sphingosine, sphingosine 1 phosphate, sterol, unclassified drug
URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85030789021&doi=10.1194%2fjlr.M078600&partnerID=40&md5=b1f61228949b2b7a6c241b8c600c3a7b
DOI10.1194/jlr.M078600
  • Google Scholar
  • RTF

Back to top

  • Access to experts
  • Technology and product development
  • Innovation skills
  • R&D funding
  • Scale-Up NZ
  • About us
  • News and events
  • Careers
  • Customer stories
  • Contact us
  • Site map

Client login (IMS)

  • Follow on
    Facebook
  • Follow on
    Twitter
  • Connect on
    LinkedIn
  • About this site
  • Privacy policy
  • Terms and conditions